Computer-Assisted Synthetic Analysis. a Rapid Computer Method for the Semiquantitative Assignment of Conformation of Six-Membered Ring Systems
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Rapid Synthesis of Oxazolines and Their Heterogeneous Oxidation to Oxazoles Under flow Cite This: Org
Organic & Biomolecular Chemistry View Article Online PAPER View Journal | View Issue The rapid synthesis of oxazolines and their heterogeneous oxidation to oxazoles under flow Cite this: Org. Biomol. Chem., 2015, 13, 207 conditions† Steffen Glöckner, Duc N. Tran, Richard J. Ingham, Sabine Fenner, Zoe E. Wilson, Claudio Battilocchio and Steven V. Ley* Received 2nd October 2014, A rapid flow synthesis of oxazolines and their oxidation to the corresponding oxazoles is reported. The Accepted 27th October 2014 oxazolines are prepared at room temperature in a stereospecific manner, with inversion of stereo- DOI: 10.1039/c4ob02105c chemistry, from β-hydroxy amides using Deoxo-Fluor®. The corresponding oxazoles can then be www.rsc.org/obc obtained via a packed reactor containing commercial manganese dioxide. 12 13 peroxide or O2 gas have also been successfully employed, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Introduction although largely for the oxidation of C5-unsubstituted oxazo- Oxazolines and oxazoles are important biological scaffolds line rings. While manganese(IV) dioxide (MnO2) has been present within many natural products (Fig. 1).1,2 Amongst the applied with some success to the preparation of thiazoles many synthetic approaches towards these structural motifs, from thiazolidines,14 to date it has not been widely used for one very useful strategy involves the cyclodehydration of the synthesis of oxazoles and only a few examples exist in the β-hydroxy amides using reagents such as Burgess’ reagent,3 literature.15,16 4 5 6 the Mitsunobu reagent, Martin sulfurane, Ph2-SO-Tf2O, We have previously described the preparation of oxazolines 7 9 PPh3-CCl4 or by treatment with fluorinating reagents such as in flow during the synthesis of o-methyl siphonazole, hennox- 8 17 18 This article is licensed under a diethylaminosulfur trifluoride (DAST) and Deoxo-Fluor®. -
Philosophy of Science and Philosophy of Chemistry
Philosophy of Science and Philosophy of Chemistry Jaap van Brakel Abstract: In this paper I assess the relation between philosophy of chemistry and (general) philosophy of science, focusing on those themes in the philoso- phy of chemistry that may bring about major revisions or extensions of cur- rent philosophy of science. Three themes can claim to make a unique contri- bution to philosophy of science: first, the variety of materials in the (natural and artificial) world; second, extending the world by making new stuff; and, third, specific features of the relations between chemistry and physics. Keywords : philosophy of science, philosophy of chemistry, interdiscourse relations, making stuff, variety of substances . 1. Introduction Chemistry is unique and distinguishes itself from all other sciences, with respect to three broad issues: • A (variety of) stuff perspective, requiring conceptual analysis of the notion of stuff or material (Sections 4 and 5). • A making stuff perspective: the transformation of stuff by chemical reaction or phase transition (Section 6). • The pivotal role of the relations between chemistry and physics in connection with the question how everything fits together (Section 7). All themes in the philosophy of chemistry can be classified in one of these three clusters or make contributions to general philosophy of science that, as yet , are not particularly different from similar contributions from other sci- ences (Section 3). I do not exclude the possibility of there being more than three clusters of philosophical issues unique to philosophy of chemistry, but I am not aware of any as yet. Moreover, highlighting the issues discussed in Sections 5-7 does not mean that issues reviewed in Section 3 are less im- portant in revising the philosophy of science. -
MS 315 A1076 Papers of Clemens Nathan Scrapbooks Containing
1 MS 315 A1076 Papers of Clemens Nathan Scrapbooks containing newspaper cuttings, correspondence and photographs from Clemens Nathan’s work with the Anglo-Jewish Association (AJA) 1/1 Includes an obituary for Anatole Goldberg and information on 1961-2, 1971-82 the Jewish youth and Soviet Jews 1/2 Includes advertisements for public meetings, information on 1972-85 the Middle East, Soviet Jews, Nathan’s election as president of the Anglo-Jewish Association and a visit from Yehuda Avner, ambassador of the state of Israel 1/3 Including papers regarding public lectures on human rights 1983-5 issues and the Nazi war criminal Adolf Eichmann, the Middle East, human rights and an obituary for Leslie Prince 1/4 Including papers regarding the Anglo-Jewish Association 1985-7 (AJA) president’s visit to Israel, AJA dinner with speaker Timothy Renton MP, Minister of State for the Foreign and Commonwealth Office; Kurt Waldheim, president of Austria; accounts for 1983-4 and an obituary for Viscount Bearsted Papers regarding Nathan’s work with the Consultative Council of Jewish Organisations (CCJO) particularly human rights issues and printed email correspondence with George R.Wilkes of Gonville and Cauis Colleges, Cambridge during a period when Nathan was too ill to attend events and regarding the United Nations sub- commission on human right at Geneva. [The CCJO is a NGO (Non-Governmental Organisation) with consultative status II at UNESCO (the United National Education, Scientific and Cultural Organisation)] 2/1 Papers, including: Jan -Aug 1998 arrangements -
Professor Binne Zwanenburg a Tribute
Issue in Honor of Prof. Binne Zwanenburg ARKIVOC 2004 (ii) 1-3 Professor Binne Zwanenburg A Tribute I cannot think of an instance, at least one of which I was aware, in the unique world of Dutch chemistry (every country has its own idiosyncrasies) when an important decision was in the air that someone did not ask "what does Binne think about this?". And I cannot remember an instance in which the position of Binne, if not yet known, was not soon made so. Binne Zwanenburg has given greatly to chemistry in general by outstanding scientific contributions and to Dutch chemistry in particular in the form of enormous and creative personal insight. Binne Zwanenburg was born in 1934 in Lippenhuizen in the province of Friesland. He grew up as a native speaker of Frisian and still has an admirable facility with this dialect (Frisians are of the opinion, not without reason, that this is a true language both spoken and written). He received his Ph.D degree in 1962 at the University of Groningen under the supervision of Wiendelt Drenth, who was later to become professor in Utrecht. He had postdoctoral positions with Ralph Raphael at Glasgow in 1963 and with Nelson Leonard at the University of Illinois in 1964/1965. He was appointed associate professor at the University of Groningen in 1965. During the period in Groningen, Binne Zwanenburg began work on organosulfur compounds in particular sulfines as well as on functionalized small-ring heterocycles. In addition to this chemistry, which quickly drew international attention, Binne became deeply involved with the plans for a new chemistry building in Groningen. -
(12) United States Patent (10) Patent N0.: US 6,967,201 B1 Briner Et Al
US006967201B1 (12) United States Patent (10) Patent N0.: US 6,967,201 B1 Briner et al. (45) Date of Patent: *Nov. 22, 2005 (54) BENZOFURYLPIPERAZINES AND (56) References Cited BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS U.S. PATENT DOCUMENTS 5,698,766 A 12/1997 Julius et 211. (75) Inventors: Karin Briner, Indianapolis, IN (US); 6,638,936 B1 * 10/2003 Briner et a1. Joseph Paul Burkhart, Plain?eld, IN (US); Timothy Paul Burkholder, FOREIGN PATENT DOCUMENTS Carmel, IN (US); Brian Eugene EP 0 006 524 A 1/1980 Cunningham, Martinsville, IN (US); EP 0 189 612 A 8/1986 Matthew Joseph Fisher, Mooresville, W0 W0 95 11243 A 4/1995 IN (US); William Harlan Gritton, W0 W0 97 08167 A 3/1997 Zionsville, IN (US); Shawn W0 W0 97 36893 A 10/1997 Christopher Miller, Noblesville, IN (US); J e?'rey Thomas Mullaney, OTHER PUBLICATIONS Indianapolis, IN (US); Matthew Robert Kuipers W. et al: “N4-unsubstituted 1-6 nl-arylpiperaZines Reinhard, Indianapolis, IN (US); as high-affinity 5 -HT1A recept r ligands” Journal of Medici Dennis Charles Thompson, nal Chemistry., vol. 38, No. 11, May 26, 1995, pp. 1942 Indianapolis, IN (US); Leonard Larry 1954, XP002153536 American Chemical Society. Washing Winneroski, Greenwood, IN (US); ton., US ISSN: 0022-2623. Yanping Xu, Fishers, IN (US) * cited by examiner (73) Assignee: Eli Lilly and Company, Indianapolis, Primary Examiner—Emily Bernhardt IN (US) (74) Attorney, Agent, or Firm—R. Craig Tucker (57) ABSTRACT (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. -
Peptide Chemistry up to Its Present State
Appendix In this Appendix biographical sketches are compiled of many scientists who have made notable contributions to the development of peptide chemistry up to its present state. We have tried to consider names mainly connected with important events during the earlier periods of peptide history, but could not include all authors mentioned in the text of this book. This is particularly true for the more recent decades when the number of peptide chemists and biologists increased to such an extent that their enumeration would have gone beyond the scope of this Appendix. 250 Appendix Plate 8. Emil Abderhalden (1877-1950), Photo Plate 9. S. Akabori Leopoldina, Halle J Plate 10. Ernst Bayer Plate 11. Karel Blaha (1926-1988) Appendix 251 Plate 12. Max Brenner Plate 13. Hans Brockmann (1903-1988) Plate 14. Victor Bruckner (1900- 1980) Plate 15. Pehr V. Edman (1916- 1977) 252 Appendix Plate 16. Lyman C. Craig (1906-1974) Plate 17. Vittorio Erspamer Plate 18. Joseph S. Fruton, Biochemist and Historian Appendix 253 Plate 19. Rolf Geiger (1923-1988) Plate 20. Wolfgang Konig Plate 21. Dorothy Hodgkins Plate. 22. Franz Hofmeister (1850-1922), (Fischer, biograph. Lexikon) 254 Appendix Plate 23. The picture shows the late Professor 1.E. Jorpes (r.j and Professor V. Mutt during their favorite pastime in the archipelago on the Baltic near Stockholm Plate 24. Ephraim Katchalski (Katzir) Plate 25. Abraham Patchornik Appendix 255 Plate 26. P.G. Katsoyannis Plate 27. George W. Kenner (1922-1978) Plate 28. Edger Lederer (1908- 1988) Plate 29. Hennann Leuchs (1879-1945) 256 Appendix Plate 30. Choh Hao Li (1913-1987) Plate 31. -
Copyrighted Material
Index Note: page numbers in italics refer to figures; those in bold to tables or boxes. abacavir 686 tolerability 536–537 children and adolescents 461 acamprosate vascular dementia 549 haematological 798, 805–807 alcohol dependence 397, 397, 402–403 see also donepezil; galantamine; hepatic impairment 636 eating disorders 669 rivastigmine HIV infection 680 re‐starting after non‐adherence 795 acetylcysteine (N‐acetylcysteine) learning disability 700 ACE inhibitors see angiotensin‐converting autism spectrum disorders 505 medication adherence and 788, 790 enzyme inhibitors obsessive compulsive disorder 364 Naranjo probability scale 811, 812 acetaldehyde 753 refractory schizophrenia 163 older people 525 acetaminophen, in dementia 564, 571 acetyl‐L‐carnitine 159 psychiatric see psychiatric adverse effects acetylcholinesterase (AChE) 529 activated partial thromboplastin time 805 renal impairment 647 acetylcholinesterase (AChE) acute intoxication see intoxication, acute see also teratogenicity inhibitors 529–543, 530–531 acute kidney injury 647 affective disorders adverse effects 537–538, 539 acutely disturbed behaviour 54–64 caffeine consumption 762 Alzheimer’s disease 529–543, 544, 576 intoxication with street drugs 56, 450 non‐psychotropics causing 808, atrial fibrillation 720 rapid tranquillisation 54–59 809, 810 clinical guidelines 544, 551, 551 acute mania see mania, acute stupor 107, 108, 109 combination therapy 536 addictions 385–457 see also bipolar disorder; depression; delirium 675 S‐adenosyl‐l‐methionine 275 mania dosing 535 ADHD -
Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]
Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved. -
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
1521-0081/67/3/601–655$25.00 http://dx.doi.org/10.1124/pr.114.010249 PHARMACOLOGICAL REVIEWS Pharmacol Rev 67:601–655, July 2015 Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics ASSOCIATE EDITOR: ELIOT H. OHLSTEIN International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors Pertti Panula, Paul L. Chazot, Marlon Cowart, Ralf Gutzmer, Rob Leurs, Wai L. S. Liu, Holger Stark, Robin L. Thurmond, and Helmut L. Haas Department of Anatomy, and Neuroscience Center, University of Helsinki, Finland (P.P.); School of Biological and Biomedical Sciences, University of Durham, United Kingdom (P.L.C.); AbbVie, Inc. North Chicago, Illinois (M.C.); Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany (R.G.); Department of Medicinal Chemistry, Amsterdam Institute of Molecules, Medicines and Systems, VU University Amsterdam, The Netherlands (R.L.); Ziarco Pharma Limited, Canterbury, United Kingdom (W.L.S.L.); Institute of Pharmaceutical and Medical Chemistry (H.S.) and Institute of Neurophysiology, Medical Faculty (H.L.H.), Heinrich-Heine-University Duesseldorf, Germany; and Janssen Research & Development, LLC, San Diego, California (R.L.T.) Abstract ....................................................................................602 Downloaded from I. Introduction and Historical Perspective .....................................................602 II. Histamine H1 Receptor . ..................................................................604 A. Receptor Structure -
Lecture 1: Strategies and Tactics in Organic Synthesis
Massachusetts Institute of Technology Organic Chemistry 5.511 October 3, 2007 Prof. Rick L. Danheiser Lecture 1: Strategies and Tactics in Organic Synthesis Retrosynthetic Analysis The key to the design of efficient syntheses ". the grand thing is to be able to reason backwards. That is a very useful accomplishment, and a very easy "The end is where we start from...." one, but people do not practice it much." T. S. Eliot, in "The Four Quartets" Sherlock Holmes, in "A Study in Scarlet" Strategy Tactics overall plan to achieve the means by which plan ultimate synthetic target is implemented intellectual experimental retrosynthetic planning synthetic execution TRANSFORMS REACTIONS Target Precursor Precursor Target Definitions Retron Structural unit that signals the application of a particular strategy algorithm during retrosynthetic analysis. Transform Imaginary retrosynthetic operation transforming a target molecule into a precursor molecule in a manner such that bond(s) can be reformed (or cleaved) by known or reasonable synthetic reactions. Strategy Algorithm Step-by-step instructions for performing a retrosynthetic operation. "...even in the earliest stages of the process of simplification of a synthetic problem, the chemist must make use of a particular form of analysis which depends on the interplay between structural features that exist in the target molecule and the types of reactions or synthetic operations available from organic chemistry for the modification or assemblage of structural units. The synthetic chemist has learned by experience to recognize within a target molecule certain units which can be synthesized, modified, or joined by known or conceivable synthetic operations...it is convenient to have a term for such units; the term "synthon" is suggested. -
[2.2]Paracyclophanes- Structure and Reactivity Studies Von Der
Syntheses of Functionalised [2.2]Paracyclophanes- Structure and Reactivity Studies Von der Gemeinsamen Naturwissenschaftlichen Fakultät der Technischen Universität Carolo Wilhelmina zu Braunschweig zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr.rer.nat.) genehmigte D i s s e r t a t i o n von Swaminathan Vijay Narayanan aus Chennai (Madras) / India 1. Referent: Prof. Dr. Dr. h. c. Henning Hopf 2. Referentin: Prof. Dr. Monika Mazik eingereicht am: 20. Jan 2005 mündliche Prüfung (Disputation) am: 29. März 2005 Druckjahr 2005 Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Gemeinsamen Naturwissenschaft-lichen Fakultät, vertreten durch die Mentorin oder den Mentor/die Betreuerin oder den Betreuer der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Publikationen K. El Shaieb, V. Narayanan, H. Hopf, I. Dix, A. Fischer, P. G. Jones, L. Ernst & K. Ibrom.: 4,15-Diamino[2.2]paracyclophane as a starting material for pseudo-geminally substituted [2.2]paracyclophanes. Eur. J. Org. Chem.: 567-577 (2003). Die vorliegende Arbeit wurde in der Zeit von Oktober 2001 bis Januar 2004 am Institut für Organische Chemie der Technischen Universität Braunschweig unter der Leitung von Prof. Dr. Dr. h.c. Henning Hopf angefertigt. It is my great pleasure to express my sincere gratitude to Prof. Dr. Henning Hopf for his support, encouragement and guidance throughout this research work. I thank him a lot for his invaluable ideas and remarks which made this study very interesting. I admire deep from my heart his energetic way of working and his brilliant ideas which made possible this research work to cover a vast area. -
Coadministration of Intramuscular Olanzapine and Benzodiazepines in Agitated Patients with Mental Illness
ORIGINAL RESEARCH Open Access Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness Andrew M. Williams, PharmD, BCPP, BCGP1 How to cite: Williams AM. Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness. Ment Health Clin [Internet]. Downloaded from http://meridian.allenpress.com/mhc/article-pdf/8/5/208/2096342/mhc_2018_09_208.pdf by guest on 29 September 2021 2018;8(5):208-13. DOI: 10.9740/mhc.2018.09.208. Abstract Introduction: Intramuscular antipsychotics are commonly used to manage agitated patients. In 2005, Eli Lilly placed a warning on olanzapine’s prescribing information following post-marketing reports of fatal drug reactions when intramuscular olanzapine was used in the setting of benzodiazepines. Data is lacking examining this drug combination. Methods: A medication use evaluation was conducted at a county psychiatric hospital surveying the usage of concomitant intramuscular olanzapine and lorazepam from October 1, 2016, to July 20, 2017. A literature search was conducted to review available evidence. Results: Ninety-one instances of the drug combination were discovered, with no serious adverse events following administration. Of these 91 patients, 41 received both medications within 60 minutes of each other. No instances of hypotension, bradycardia, bradypnea, or oxygen desaturation occurred following administration. The literature review yielded 1 randomized, placebo-controlled clinical trial, 3 retrospective chart reviews, and several case studies. Discussion: Data detailing a causal relationship between olanzapine/benzodiazepine combinations and serious adverse effects is lacking. Available evidence does not consistently support a strong cause and effect relationship. The results of this medication use evaluation are not consistent with the Food and Drug Administration warning.